These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11669408)

  • 1. Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: implication for coronary arteriosclerosis.
    Watanabe K; Fukuda H; Sueda S; Funada J; Kitakaze M; Sekiya M
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):147-53. PubMed ID: 11669408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].
    Nishimura M; Ushiyama M; Nanbu A; Ohtsuka K; Yoshimura M
    Rinsho Byori; 1998 Jul; 46(7):671-7. PubMed ID: 9721534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of serum hepatocyte growth factor in coronary artery disease].
    Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
    J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease.
    Tateishi J; Waku S; Masutani M; Ohyanagi M; Iwasaki T
    Am Heart J; 2002 Feb; 143(2):272-6. PubMed ID: 11835030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum hepatocyte growth factor as a possible indicator of vascular lesions].
    Nishimura M; Ushiyama M; Yoshimura M
    Rinsho Byori; 1997 Sep; 45(9):831-6. PubMed ID: 9311255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for association of coronary sinus levels of hepatocyte growth factor and collateralization in human coronary disease.
    Lenihan DJ; Osman A; Sriram V; Aitsebaomo J; Patterson C
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1507-12. PubMed ID: 12521946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction.
    Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
    Circ J; 2002 Nov; 66(11):1003-7. PubMed ID: 12419930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there].
    Wang NF; Tong GX; Li PZ; Zhang XW; Xu J; Wu GP; Jin JF; Zhou L; Ye XH; Yang JM; Pan H
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1411-3. PubMed ID: 17785064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension.
    Nakamura S; Moriguchi A; Morishita R; Aoki M; Yo Y; Hayashi S; Nakano N; Katsuya T; Nakata S; Takami S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Biochem Biophys Res Commun; 1998 Jan; 242(1):238-43. PubMed ID: 9439642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor and 24-hour ambulatory blood pressure monitoring.
    Hayashi Y; Saitoh S; Takagi S; Tuchihashi K; Miura T; Shimamoto K
    Hypertens Res; 2002 Sep; 25(5):655-60. PubMed ID: 12452315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor production may be related to the inflammatory response in patients with acute myocardial infarction.
    Shimada Y; Yoshiyama M; Jissho S; Kamimori K; Nakamura Y; Iida H; Takeuchi K; Yoshikawa J
    Circ J; 2002 Mar; 66(3):253-6. PubMed ID: 11922273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.
    Nakamura Y; Morishita R; Nakamura S; Aoki M; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1996 Sep; 28(3):409-13. PubMed ID: 8794825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
    Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
    Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic aortic arteriosclerosis in patients with degenerative aortic stenosis with and without coexisting coronary artery disease.
    Goland S; Trento A; Czer LS; Eshaghian S; Tolstrup K; Naqvi TZ; De Robertis MA; Mirocha J; Iida K; Siegel RJ
    Ann Thorac Surg; 2008 Jan; 85(1):113-9. PubMed ID: 18154793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease.
    Suzuki H; Murakami M; Shoji M; Iso Y; Kondo T; Shibata M; Ezumi H; Hamazaki Y; Koba S; Katagiri T
    Coron Artery Dis; 2003 Jun; 14(4):301-7. PubMed ID: 12826929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
    Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
    Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor as a potential index of complication in diabetes mellitus.
    Nakamura S; Morishita R; Moriguchi A; Yo Y; Nakamura Y; Hayashi S; Matsumoto K; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Hypertens; 1998 Dec; 16(12 Pt 2):2019-26. PubMed ID: 9886892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial.
    Montorsi P; Ravagnani PM; Galli S; Rotatori F; Veglia F; Briganti A; Salonia A; Dehò F; Rigatti P; Montorsi F; Fiorentini C
    Eur Heart J; 2006 Nov; 27(22):2632-9. PubMed ID: 16854949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension.
    Liang M; Pang Y; Zhang S; Zhang M
    Mol Diagn Ther; 2016 Oct; 20(5):463-8. PubMed ID: 27342109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.